News Releases

LOUISVILLE, Ky., May 27, 2010 (BUSINESS WIRE) --PharMerica Corporation (NYSE: PMC) announced the results of the Company's 2010 annual meeting of stockholders held on Wednesday, May 26, 2010.

At the annual meeting of stockholders, the following current directors were elected to serve on the Board of Directors until the annual meeting of stockholders in 2011: Frank E. Collins, Esq., W. Robert Dahl, Jr., Marjorie W. Dorr, Thomas P. Gerrity, Ph.D., Thomas P. Mac Mahon, Daniel N. Mendelson, Robert A. Oakley, Ph.D., Geoffrey G. Meyers and Gregory S. Weishar. Stockholders also voted to approve the Company's Amendment and Restatement of the Amended and Restated 2007 Omnibus Incentive Plan and ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2010.

About PharMerica

PharMerica Corporation is a leading institutional pharmacy services company servicing healthcare facilities in the United States. PharMerica operates institutional pharmacies in 41 states. PharMerica's customers are institutional healthcare providers, such as nursing centers, assisted living facilities, hospitals and other long-term care providers. The Company also provides pharmacy management services to long-term care hospitals.

SOURCE: PharMerica Corporation

PharMerica Corporation
Michael J. Culotta, 502-627-7475
Executive Vice President and Chief Financial Officer